查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1701982

2025 年至 2033 年氣霧劑輸送設備市場報告（按產品、應用（氣喘、慢性阻塞性肺病、囊性纖維化、非呼吸系統疾病）、配銷通路和地區分類）

Aerosol Delivery Devices Market Report by Product, Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球氣霧劑輸送裝置市場規模達 495 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 752 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.8%。市場的主要促進因素是呼吸系統疾病發病率的上升、吸入技術的進步、老年人口的成長、醫療保健成本的上升以及全球對定製藥物可用性的認知的提高。

氣霧劑輸送裝置用於輸送藥物和治療呼吸系統疾病，例如氣喘、阻塞性肺病、囊性纖維化、肺動脈高壓、傳染性肺病。它們降低了劑量要求，減少了全身不良反應，並提高了患者自我用藥的能力。一些常見的氣霧劑輸送裝置是加壓定量吸入器、霧化器和帶閥容器。目前，隨著新型大分子藥物的出現，智慧氣霧劑給藥裝置已應用於糖尿病、鎮痛、甲狀腺疾病、遺傳性疾病等非呼吸系統疾病的治療。

氣霧劑輸送裝置市場趨勢：

冠狀病毒病（COVID-19）在全球爆發，導致患者急性呼吸道感染，這是推動氣霧劑輸送裝置需求的關鍵因素之一。這些設備有助於在家中和醫療保健環境中治療阻塞性呼吸道疾病。除此之外，由於空氣污染水平、過敏原和職業風險的增加，慢性呼吸道感染的盛行率不斷上升，以及吸菸和飲酒人數的增加，正在推動市場的成長。此外，老年人口的大幅增加，更容易患上嚴重的健康疾病，對方便、經濟的攜帶式吸入裝置的需求產生了積極影響。除此之外，市場參與者正在開發新型氣霧輸送裝置，幫助治療肺部慢性發炎和感染，並改善囊性纖維化 (CF) 患者的呼吸道清除。此外，他們還透過電子商務管道提供具有自動記憶功能且易於旅行時使用的迷你超音波霧化器和吸入器。這與個人化藥物治療需求的不斷成長以及擴大使用線上管道購買醫療用品一起推動了市場的發展。

本報告回答的關鍵問題

  • 2024 年全球氣霧劑輸送裝置市場規模？ 2025 年至 2033 年期間全球氣霧劑輸送裝置市場的預期成長率為何？
  • 推動全球氣霧劑輸送裝置市場發展的關鍵因素有哪些？
  • COVID-19 對全球氣霧劑輸送裝置市場有何影響？
  • 根據產品，全球氣霧劑輸送裝置市場是如何分佈的？
  • 根據配銷通路，全球氣霧劑輸送裝置市場如何分佈？
  • 全球氣霧劑輸送裝置市場的主要區域有哪些？
  • 全球氣霧劑輸送裝置市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球氣霧劑輸送裝置市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 乾粉吸入器
    • 關鍵部分
      • 單劑量吸入器
      • 多劑量吸入器
  • 定量吸入器
    • 關鍵部分
      • 傳統加壓吸入器
      • 軟霧吸入器
  • 霧化器
    • 關鍵部分
      • 噴射霧化器
      • 超音波霧化器
      • 振動網狀霧化器

第7章：市場區隔：依應用

  • 氣喘
  • 慢性阻塞性肺病（COPD）
  • 囊腫纖維化
  • 非呼吸系統疾病
    • 關鍵部分
      • 糖尿病
      • 鎮痛
      • 帕金森氏症

第8章：市場區隔：按配銷通路

  • 零售藥局
  • 醫院藥房
  • 網路商店

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Aerogen
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Koninklijke Philips NV
    • Merck & Co. Inc.
    • Metall Zug AG
    • Recipharm AB (publ)
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
Product Code: SR112025A4892

The global aerosol delivery devices market size reached USD 49.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 75.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is primarily driven by the rising rates of respiratory illnesses, improvements in inhalation technology, growing geriatric population, rising healthcare costs, and a growing global awareness regarding the availability of customized medicine.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

Breakup by Product:

  • Dry Powder Inhalers
  • Single Dose Inhalers
  • Multi Dose Inhalers
  • Metered Dose Inhalers
  • Conventional Pressurized Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Jet Nebulizers
  • Ultrasonic Wave Nebulizers
  • Vibrating Mesh Nebulizers

Breakup by Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
  • Diabetes
  • Analgesia
  • Parkinson's Disease

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1.What was the size of the global aerosol delivery devices market in 2024?
  • 2.What is the expected growth rate of the global aerosol delivery devices market during 2025-2033?
  • 3.What are the key factors driving the global aerosol delivery devices market?
  • 4.What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • 5.What is the breakup of the global aerosol delivery devices market based on the product?
  • 6.What is the breakup of the global aerosol delivery devices market based on the distribution channel?
  • 7.What are the key regions in the global aerosol delivery devices market?
  • 8.Who are the key players/companies in the global aerosol delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aerosol Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dry Powder Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Single Dose Inhalers
      • 6.1.2.2 Multi Dose Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Metered Dose Inhalers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Conventional Pressurized Inhalers
      • 6.2.2.2 Soft Mist Inhalers
    • 6.2.3 Market Forecast
  • 6.3 Nebulizers
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Jet Nebulizers
      • 6.3.2.2 Ultrasonic Wave Nebulizers
      • 6.3.2.3 Vibrating Mesh Nebulizers
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cystic Fibrosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Non-Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Key Segments
      • 7.4.2.1 Diabetes
      • 7.4.2.2 Analgesia
      • 7.4.2.3 Parkinson's Disease
    • 7.4.3 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aerogen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 GlaxoSmithKline plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Koninklijke Philips N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Metall Zug AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Recipharm AB (publ)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
  • Table 7: Global: Aerosol Delivery Devices Market: Key Players